# Cancer and cancer services in Syria during the conflict: a systematic review

Source: https://onco.cc/key-papers/paper-basha-cancer-syria-conflict-review-bmc-cancer-2024/  
OnCo record `paper-basha-cancer-syria-conflict-review-bmc-cancer-2024` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A review of 28 English and Arabic studies and reports from March 2011 to February 2024 found cancer services concentrated in Damascus, shortages of staff, chemotherapy and radiotherapy, little screening or palliative care, and no working national cancer registry since 2011.

## Summary

Published as "Cancer and Syria in conflict: a systematic review". The authors searched eight academic and six grey literature databases for studies published from March 2011 to February 2024 and included 28 (23 academic, 5 grey literature). In the full text they record that the Syrian National Cancer Registry was set up in 2002 as a hospital-based registry drawing on hospital records and some pathology laboratories, that support from IARC had become more erratic by 2007, and that the conflict from 2011 halted it completely, so national estimates since then rest on extrapolation.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: BMC Cancer
- Year: 2024
- DOI: 10.1186/s12885-024-13256-9
- Authors: Basha L, Ahmed H, Hamze M, et al.
- Findings: 28 of 5,801 records identified were eligible.; Papers reporting on burden showed an overall rise in estimated cancer incidence and mortality between 2012 and 2022.; Most services were concentrated in Damascus; staff shortages, chemotherapy shortages, insufficient radiotherapy and a lack of screening and palliative care were the main themes.
- What it means: This is the most complete map of what is known about cancer care in Syria during the conflict, and it shows how little is measured: the authors report no national cancer registry from 2011 onwards.
- Caveats: Few high-quality studies; much of the evidence is grey literature or single-hospital series.; Searches ended in February 2024, before the transfer of authority WHO referred to on 24 December 2024.

## Sources

- BMC Cancer 2024: https://doi.org/10.1186/s12885-024-13256-9
- PubMed: https://pubmed.ncbi.nlm.nih.gov/39695449/

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/), [Lung cancer (all types)](https://onco.cc/cancers/lung-cancer/)
- institutions: [Al-Bairouni University Hospital](https://onco.cc/institutions/al-bairouni-university-hospital/), [Idlib Oncology Centre (Syrian American Medical Society)](https://onco.cc/institutions/idlib-oncology-centre-sams/), [Ministry of Health, Syrian Arab Republic](https://onco.cc/institutions/syria-ministry-of-health/), [Tishreen University Hospital](https://onco.cc/institutions/tishreen-university-hospital/)

---
JSON: https://onco.cc/api/v1/entities/paper-basha-cancer-syria-conflict-review-bmc-cancer-2024.json